PAPD5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.015000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.613200E-01
Normal-vs-Stage2
4.618800E-01
Normal-vs-Stage3
2.100500E-03
Normal-vs-Stage4
7.657400E-01
Stage1-vs-Stage2
7.600800E-01
Stage1-vs-Stage3
3.638300E-02
Stage1-vs-Stage4
3.950200E-01
Stage2-vs-Stage3
4.26319999999869E-05
Stage2-vs-Stage4
2.429000E-01
Stage3-vs-Stage4
4.403600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.019400E-01
Normal-vs-AfricanAmerican
7.217800E-01
Normal-vs-Asian
4.728400E-02
Caucasian-vs-AfricanAmerican
1.356020E-01
Caucasian-vs-Asian
1.032000E-01
AfricanAmerican-vs-Asian
1.444390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.275800E-01
Normal-vs-Female
4.844400E-01
Male-vs-Female
9.424400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.341800E-01
Normal-vs-Age(41-60Yrs)
8.786400E-01
Normal-vs-Age(61-80Yrs)
3.639600E-01
Normal-vs-Age(81-100Yrs)
1.058050E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.941800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.378400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.516600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.845910E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.316000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.304600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.500100E-02
Normal-vs-Daily Drinker
1.000810E-01
Normal-vs-Weekly Drinker
1.123620E-01
Normal-vs-Occasional Drinker
9.842600E-01
Normal-vs-Social Drinker
7.711800E-01
Non Drinker-vs-Daily Drinker
8.500600E-01
Non Drinker-vs-Weekly Drinker
8.726800E-01
Non Drinker-vs-Occasional Drinker
1.019630E-01
Non Drinker-vs-Social Drinker
1.398650E-01
Daily Drinker-vs-Weekly Drinker
9.952800E-01
Daily Drinker-vs-Occasional Drinker
9.470200E-02
Daily Drinker-vs-Social Drinker
1.298220E-01
Weekly Drinker-vs-Occasional Drinker
1.065010E-01
Weekly Drinker-vs-Social Drinker
1.549370E-01
Occasional Drinker-vs-Social Drinker
7.125800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.023400E-01
Normal-vs-Grade 2
8.208500E-02
Normal-vs-Grade 3
4.310200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.943000E-01
Grade 1-vs-Grade 3
7.954600E-01
Grade 1-vs-Grade 4
2.023400E-01
Grade 2-vs-Grade 3
6.872400E-01
Grade 2-vs-Grade 4
8.208500E-02
Grade 3-vs-Grade 4
4.310200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.529000E-01
Normal-vs-NonDiabetic
4.809000E-01
Diabetic-vs-NonDiabetic
5.303600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.756400E-02
Normal-vs-NoPancreatitis
5.006600E-01
Pancreatitis-vs-NoPancreatitis
3.504000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.652400E-01
Normal-vs-N1
5.036400E-01
N0-vs-N1
8.504200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.260000E-01
Normal-vs-TP53-NonMutant
6.228400E-01
TP53-Mutant-vs-TP53-NonMutant
9.923200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
